Charleston, SC -- (SBWIRE) -- 09/12/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Cereplast Inc (OTCMKTS:CERP), Blue Earth Inc (OTCMKTS:BBLU), Epazz Inc (OTCMKTS:EPAZ), Nutra Pharma Corp. (OTCMKTS:NPHC)
Cereplast Inc (OTCMKTS:CERP) remained a bull for the day as it reported the upward momentum of +2.56% and closed at $0.0160 after gaining total volume of 7.13 million shares. Its introductory price for the day was $0.02. So far, the company’s stock is down -37.98% in the three months period. In the last 6 months of trade it reported a decline of -51.52%.
Cereplast, Inc. develops and commercializes bio-based resins. It provides Cereplast Compostables resins, which are compostable, bio-based, and ecologically sound substitutes for petroleum-based plastics targeting compostable bags, single-use food service products, and packaging applications.
For How Long CERP will Fight for Profitability? Read This Trend Analysis report
Blue Earth Inc (OTCMKTS:BBLU) reported the gain of +2.58% and closed at $ 3.18 with the total traded volume of 81,175 shares. The stock's opening price was $ 3.11. The company has a total market capitalization of $ 153.21 million.
The 52-week price range of the stock remained $0.82 - $3.89, while during last trade its minimum price was $3.02 and it gained its highest price of $3.20. Company's last 5 days shows a down turn with a decline of -6.47%. Blue Earth, Inc. engages in a mergers and acquisition strategy to acquire, license, develop, market, install, and monitor clean-tech related technologies and energy management systems.
What was the Moving Force behind BBLU On Bullish Run? Read This Research Report
Epazz Inc (OTCMKTS:EPAZ) ended its day with the gaining stream with the rise of +9.09% and closed at the price of $0.0012 after opening at $0.0011. Stock traded during its last trading session with the total volume of 25.75 million shares, as compared to its average volume of 15.82 million shares.
During the previous session, the company’s minimum price was $0.001, while it touched its highest price for the day at $0.0014. EPAZ’s beta value stands at 8.42 points. Epazz, Inc., together with its subsidiaries, designs and sells various software programs to business enterprises, hospitals, and government and post-secondary institutions in the United States.
Why Should Investors Buy EPAZ After The Recent Gain? Just Go Here and Find Out
Nutra Pharma Corp. (OTCMKTS:NPHC) reported the gain of +10.18%, to close at $0.0184, with the overall traded volume of 4.73 million shares.
So far, in the past three months, the stock is up +201.64%. The 52-week range for the stock is $0.0035 and $0.0445 and during the previous trading session the stock touched its highest price at $0.0191. Its introductory price for the day was $0.017. Nutra Pharma Corporation, a biotechnology company, engages in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases.
For How Long NPHC will Fight for Profitability? Read This Trend Analysis report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)